Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Sickle cell disease (SCD) is a chronic, inherited blood disorder that impacts hemoglobin, a protein found in red blood cells (RBCs) that carries oxygen throughout the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglobin known as sickle hemoglobin (HbS).
In the last several years, global market of Sickle Cell Anemia Therapeutics developed rapidly, with an average growth rate of 13% during 2015 to 2019. In 2019, global revenue of Sickle Cell Anemia Therapeutics is nearly 1900 M USD.
The report details the trend, potential and market size of Sickle-cell Anemia Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Sickle-cell Anemia Therapeuticsmarket, defines the market attractiveness level of Sickle-cell Anemia Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Sickle-cell Anemia Therapeutics industry, describes the types of Sickle-cell Anemia Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Sickle-cell Anemia Therapeutics market and the development prospects and opportunities of Sickle-cell Anemia Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Sickle-cell Anemia Therapeutics market in Chapter 13.
By Player:
Selexys Pharmaceuticals
Baxter
Bristol-Myers Squibb
Bluebird Bio
Daiichi Sankyo
GlycoMimetics
Eli Lilly
Mast Therapeutics
Pfizer
Merck Sharp and Dohme
Emmaus Medical
HemaQuest Pharmaceuticals
By Type:
Vaccination and Antibiotics
High Fluid Intake
Folic Acid Supplementation
Pain Medication
Other
By End-User:
Hospitals
Clinics
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Sickle-cell Anemia Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Sickle-cell Anemia Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Sickle-cell Anemia Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Sickle-cell Anemia Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Sickle-cell Anemia Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Sickle-cell Anemia Therapeutics Consumption (2017-2022)
-
7.2 United States Sickle-cell Anemia Therapeutics Consumption (2017-2022)
-
7.3 Europe Sickle-cell Anemia Therapeutics Consumption (2017-2022)
-
7.4 China Sickle-cell Anemia Therapeutics Consumption (2017-2022)
-
7.5 Japan Sickle-cell Anemia Therapeutics Consumption (2017-2022)
-
7.6 India Sickle-cell Anemia Therapeutics Consumption (2017-2022)
-
7.7 South Korea Sickle-cell Anemia Therapeutics Consumption (2017-2022)
8 Region and Country-wise Sickle-cell Anemia Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Sickle-cell Anemia Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Sickle-cell Anemia Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Sickle-cell Anemia Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Sickle-cell Anemia Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Sickle-cell Anemia Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Sickle-cell Anemia Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Sickle-cell Anemia Therapeutics Consumption Forecast (2022-2028)
9 Global Sickle-cell Anemia Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Sickle-cell Anemia Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Vaccination and Antibiotics Consumption and Growth Rate (2017-2022)
-
9.1.2 Global High Fluid Intake Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Folic Acid Supplementation Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Pain Medication Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Sickle-cell Anemia Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Sickle-cell Anemia Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Sickle-cell Anemia Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Vaccination and Antibiotics Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global High Fluid Intake Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Folic Acid Supplementation Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Pain Medication Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Sickle-cell Anemia Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Sickle-cell Anemia Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Sickle-cell Anemia Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Sickle-cell Anemia Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Sickle-cell Anemia Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Sickle-cell Anemia Therapeutics Market Competitive Analysis
-
14.1 Selexys Pharmaceuticals
-
14.1.1 Selexys Pharmaceuticals Company Details
-
14.1.2 Selexys Pharmaceuticals Sickle-cell Anemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Selexys Pharmaceuticals Sickle-cell Anemia Therapeutics Product and Service
-
14.2 Baxter
-
14.2.1 Baxter Company Details
-
14.2.2 Baxter Sickle-cell Anemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Baxter Sickle-cell Anemia Therapeutics Product and Service
-
14.3 Bristol-Myers Squibb
-
14.3.1 Bristol-Myers Squibb Company Details
-
14.3.2 Bristol-Myers Squibb Sickle-cell Anemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Bristol-Myers Squibb Sickle-cell Anemia Therapeutics Product and Service
-
14.4 Bluebird Bio
-
14.4.1 Bluebird Bio Company Details
-
14.4.2 Bluebird Bio Sickle-cell Anemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Bluebird Bio Sickle-cell Anemia Therapeutics Product and Service
-
14.5 Daiichi Sankyo
-
14.5.1 Daiichi Sankyo Company Details
-
14.5.2 Daiichi Sankyo Sickle-cell Anemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Daiichi Sankyo Sickle-cell Anemia Therapeutics Product and Service
-
14.6 GlycoMimetics
-
14.6.1 GlycoMimetics Company Details
-
14.6.2 GlycoMimetics Sickle-cell Anemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 GlycoMimetics Sickle-cell Anemia Therapeutics Product and Service
-
14.7 Eli Lilly
-
14.7.1 Eli Lilly Company Details
-
14.7.2 Eli Lilly Sickle-cell Anemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Eli Lilly Sickle-cell Anemia Therapeutics Product and Service
-
14.8 Mast Therapeutics
-
14.8.1 Mast Therapeutics Company Details
-
14.8.2 Mast Therapeutics Sickle-cell Anemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Mast Therapeutics Sickle-cell Anemia Therapeutics Product and Service
-
14.9 Pfizer
-
14.9.1 Pfizer Company Details
-
14.9.2 Pfizer Sickle-cell Anemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Pfizer Sickle-cell Anemia Therapeutics Product and Service
-
14.10 Merck Sharp and Dohme
-
14.10.1 Merck Sharp and Dohme Company Details
-
14.10.2 Merck Sharp and Dohme Sickle-cell Anemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Merck Sharp and Dohme Sickle-cell Anemia Therapeutics Product and Service
-
14.11 Emmaus Medical
-
14.11.1 Emmaus Medical Company Details
-
14.11.2 Emmaus Medical Sickle-cell Anemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Emmaus Medical Sickle-cell Anemia Therapeutics Product and Service
-
14.12 HemaQuest Pharmaceuticals
-
14.12.1 HemaQuest Pharmaceuticals Company Details
-
14.12.2 HemaQuest Pharmaceuticals Sickle-cell Anemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 HemaQuest Pharmaceuticals Sickle-cell Anemia Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Sickle-cell Anemia Therapeutics
-
Figure Sickle-cell Anemia Therapeutics Picture
-
Table Global Sickle-cell Anemia Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Sickle-cell Anemia Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Sickle-cell Anemia Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Sickle-cell Anemia Therapeutics Consumption by Country (2017-2022)
-
Figure United States Sickle-cell Anemia Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Sickle-cell Anemia Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Sickle-cell Anemia Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Sickle-cell Anemia Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Sickle-cell Anemia Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Sickle-cell Anemia Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Sickle-cell Anemia Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Sickle-cell Anemia Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Sickle-cell Anemia Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Sickle-cell Anemia Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Sickle-cell Anemia Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Sickle-cell Anemia Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Sickle-cell Anemia Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Vaccination and Antibiotics Consumption and Growth Rate (2017-2022)
-
Figure Global High Fluid Intake Consumption and Growth Rate (2017-2022)
-
Figure Global Folic Acid Supplementation Consumption and Growth Rate (2017-2022)
-
Figure Global Pain Medication Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Vaccination and Antibiotics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global High Fluid Intake Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Folic Acid Supplementation Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pain Medication Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Sickle-cell Anemia Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Sickle-cell Anemia Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Selexys Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Selexys Pharmaceuticals Sickle-cell Anemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Selexys Pharmaceuticals Sickle-cell Anemia Therapeutics Product and Service
-
Table Baxter (Foundation Year, Company Profile and etc.)
-
Table Baxter Sickle-cell Anemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Baxter Sickle-cell Anemia Therapeutics Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Sickle-cell Anemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Sickle-cell Anemia Therapeutics Product and Service
-
Table Bluebird Bio (Foundation Year, Company Profile and etc.)
-
Table Bluebird Bio Sickle-cell Anemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bluebird Bio Sickle-cell Anemia Therapeutics Product and Service
-
Table Daiichi Sankyo (Foundation Year, Company Profile and etc.)
-
Table Daiichi Sankyo Sickle-cell Anemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Daiichi Sankyo Sickle-cell Anemia Therapeutics Product and Service
-
Table GlycoMimetics (Foundation Year, Company Profile and etc.)
-
Table GlycoMimetics Sickle-cell Anemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlycoMimetics Sickle-cell Anemia Therapeutics Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Sickle-cell Anemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Sickle-cell Anemia Therapeutics Product and Service
-
Table Mast Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Mast Therapeutics Sickle-cell Anemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mast Therapeutics Sickle-cell Anemia Therapeutics Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Sickle-cell Anemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Sickle-cell Anemia Therapeutics Product and Service
-
Table Merck Sharp and Dohme (Foundation Year, Company Profile and etc.)
-
Table Merck Sharp and Dohme Sickle-cell Anemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Sharp and Dohme Sickle-cell Anemia Therapeutics Product and Service
-
Table Emmaus Medical (Foundation Year, Company Profile and etc.)
-
Table Emmaus Medical Sickle-cell Anemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Emmaus Medical Sickle-cell Anemia Therapeutics Product and Service
-
Table HemaQuest Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table HemaQuest Pharmaceuticals Sickle-cell Anemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table HemaQuest Pharmaceuticals Sickle-cell Anemia Therapeutics Product and Service
-
